Literature DB >> 17952291

McArdle disease with rhabdomyolysis induced by rosuvastatin: case report.

Paulo José Lorenzoni1, Carlos Eduardo Silvado, Rosana Herminia Scola, Mario Luvizotto, Lineu César Werneck.   

Abstract

The rosuvastatin inducing rhabdomyolysis in McArdle disease (MD) has not been reported to date. A 35-years-old man had exercise intolerance, muscular fatigue and cramps during physical activity since infancy. He presented severe rhabdomyolysis episode with seizure and coma after use of rosuvastatin. The investigation showed increased serum creatine-kinase levels and the forearm ischemic exercise did not increase venous lactate. The muscle biopsy showed subsarcolemmal and central accumulation of glycogen and absence of the myophosphorylase enzyme. The statin induced myopathy is discussed and the danger of its use in MD is emphasized.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17952291     DOI: 10.1590/s0004-282x2007000500020

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  6 in total

1.  Statin-induced muscle toxicity and susceptibility to malignant hyperthermia and other muscle diseases: a population-based case-control study including 1st and 2nd degree relatives.

Authors:  Karin Hedenmalm; Arzu Gunes Granberg; Marja-Liisa Dahl
Journal:  Eur J Clin Pharmacol       Date:  2014-11-01       Impact factor: 2.953

2.  Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.

Authors:  Liam R Brunham; Steven Baker; Andrew Mammen; G B John Mancini; Robert S Rosenson
Journal:  Cardiovasc Res       Date:  2018-07-01       Impact factor: 10.787

3.  McArdle's disease in the seventh decade: challenges in diagnosis and management.

Authors:  Marta Almeida Ferreira; Arlindo Guimas; Raquel Faria
Journal:  Endocrine       Date:  2014-02-04       Impact factor: 3.633

4.  Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.

Authors:  Judit Núñez-Manchón; Alfonsina Ballester-Lopez; Emma Koehorst; Ian Linares-Pardo; Daniëlle Coenen; Ignacio Ara; Carlos Rodriguez-Lopez; Alba Ramos-Fransi; Alicia Martínez-Piñeiro; Giuseppe Lucente; Miriam Almendrote; Jaume Coll-Cantí; Guillem Pintos-Morell; Alejandro Santos-Lozano; Joaquin Arenas; Miguel Angel Martín; Mauricio de Castro; Alejandro Lucia; Alfredo Santalla; Gisela Nogales-Gadea
Journal:  J Inherit Metab Dis       Date:  2018-06-20       Impact factor: 4.982

Review 5.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

6.  Statin use in patients with non-HMGCR idiopathic inflammatory myopathies: A retrospective study.

Authors:  Sangmee Sharon Bae; Buzand Oganesian; Ilana Golub; Christina Charles-Schoeman
Journal:  Clin Cardiol       Date:  2020-05-20       Impact factor: 2.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.